Understanding these glycosylation patterns is just as important as analyzing other tools like labeled peptides, which are ...

August 05, 2025 - The growing prevalence of chronic illnesses is a major factor driving revenue growth in the bispecific ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and the neonatal Fc receptor (FcRn). FcRn is central to the body’s ability to ...

For the first time, scientists in Australia have visualized a vital protein structure within malaria parasites, unveiling a ...

Detailed price information for Immunoprecise Antibodies Ltd (IPA-Q) from The Globe and Mail including charting and trades.

Syndax Pharmaceuticals (NASDAQ:SNDX) posted GAAP revenue of $38.0 million in Q2 2025 and far above analyst estimates. GAAP net loss per share was $ (0.83) for Q2 2025, a narrower GAAP loss than the $ ...

Partial responses observed in 80% of squamous NSCLC front-line patients and in 46% of non-squamous NSCLC front-line patients ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Key Points OJEMDA net product revenue surged 310% year over year to $33.6 million in Q2 2025, driving total quarterly revenue (GAAP) to $33.9 million but narrowly missed consensus expectations for ...

Vir Biotech begins patient dosing in phase 1 trial of EGFR-targeting PRO-XTEN dual-masked T-cell engager VIR-5525 to treat solid tumours: San Francisco Saturday, July 26, 2025, 12 ...

Formation Bio, an AI-native pharma company, and IMIDomics, a precision medicine company focused on immune-mediated inflammatory diseases today announced that Formation Bio has licensed worldwide ...

Key Laboratory of Agricultural Biosafety and Green Production of Upper Yangtze River (Ministry of Education), College of Horticulture and Landscape Architecture, Southwest University, Chongqing, China ...